Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CNS Lymphoma”

673 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 673 results

Very early researchActive Not RecruitingNCT03684980
What this trial is testing

LTA Pilot Study of Glucarpidase in Patients With Central Nervous System Lymphoma

Who this might be right for
Central Nervous System Lymphoma
Memorial Sloan Kettering Cancer Center 58
Testing effectiveness (Phase 2)Study completedNCT06439420
What this trial is testing

CBT-I in Primary Brain Tumor Patients: Phase IIc Randomized Feasibility Pilot Trial

Who this might be right for
Primary Brain TumorGlioblastomaAstrocytoma+3 more
Virginia Commonwealth University 70
Not applicableStudy completedNCT05169203
What this trial is testing

The Use of Biomarkers to Predict CNS Involvement in Diffuse Large B-Cell Lymphoma: a Danish Nationwide Registry Study

Who this might be right for
Diffuse Large B Cell LymphomaDiffuse Large B-Cell Lymphoma Cell of OriginDiffuse Large B-cell Lymphoma Recurrent
Herlev Hospital 2,969
Testing effectiveness (Phase 2)Ended earlyNCT01065805
What this trial is testing

Demonstrate the Safety and Preliminary Efficacy of 18F-FLT in Patients With Solid Tumours or Lymphoma

Who this might be right for
Brain CancerCancerSolid Tumor+1 more
AHS Cancer Control Alberta 94
Not applicableLooking for participantsNCT06817122
What this trial is testing

The "Let's Talk Tech" Tool to Support Decision Making About Technology Use

Who this might be right for
Dementia, MildMild Cognitive Impairment (MCI)
University of Washington 240
Testing effectiveness (Phase 2)Looking for participantsNCT06687772
What this trial is testing

CNS-Relapse Prevention in High-Risk Diffuse Large B-cell Lymphoma With Thiotepa-based Autologous Stem Cell Transplant

Who this might be right for
Diffuse Large B Cell Lymphoma
Washington University School of Medicine 36
Not applicableLooking for participantsNCT06444841
What this trial is testing

Paper-Based and Smartphone-Based Memory Supports

Who this might be right for
Alzheimer DiseaseDementia, MildMild Cognitive Impairment
Baylor University 200
Early research (Phase 1)Study completedNCT00916630
What this trial is testing

Treatment of Recurrent Primary or Secondary Central Nervous System (CNS) Lymphoma With ALIMTA (Pemetrexed)

Who this might be right for
Central Nervous System Lymphoma
Massachusetts General Hospital 18
Testing effectiveness (Phase 2)Looking for participantsNCT05681195
What this trial is testing

Zanubrutinib With Pemetrexed to Treat Relapsed/Refractory Primary and Secondary Central Nervous System (CNS) Lymphomas

Who this might be right for
Primary Central Nervous System LymphomaSecondary Central Nervous System LymphomaRelapsed Cancer+1 more
Baptist Health South Florida 15
Testing effectiveness (Phase 2)Ended earlyNCT02420795
What this trial is testing

Akt/ERK Inhibitor ONC201 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Central Nervous System LymphomaGastric Mantle Cell LymphomaRecurrent Mantle Cell Lymphoma+4 more
M.D. Anderson Cancer Center 16
Testing effectiveness (Phase 2)Looking for participantsNCT05951777
What this trial is testing

Autologous Adipose-Derived Mesenchymal Stem Cells for Chronic Traumatic Brain Injury

Who this might be right for
Traumatic Brain Injury
Hope Biosciences LLC 51
Not applicableStudy completedNCT00002520
What this trial is testing

Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+7 more
Eastern Cooperative Oncology Group 434
Early research (Phase 1)Looking for participantsNCT05131022
What this trial is testing

NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)Diffuse Large B Cell Lymphoma (DLBCL)+6 more
Nurix Therapeutics, Inc. 572
Early research (Phase 1)Study completedNCT02323880
What this trial is testing

Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas

Who this might be right for
Malignant GliomaRecurrent Brain NeoplasmRecurrent Childhood Central Nervous System Neoplasm+7 more
Children's Oncology Group 59
Not applicableStudy completedNCT00416819
What this trial is testing

Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Primary CNS Lymphoma

Who this might be right for
Brain and Central Nervous System TumorsLymphoma
University of California, San Francisco 10
Testing effectiveness (Phase 2)UnknownNCT04438044
What this trial is testing

Evaluate ICP-022 in Patients With R/R PCNSL and SCNSL

Who this might be right for
PCNSLSecondary Central Nervous System Lymphoma
Beijing InnoCare Pharma Tech Co., Ltd. 61
Early research (Phase 1)Looking for participantsNCT04807881
What this trial is testing

Phase Ib Clinical Study of Keynatinib

Who this might be right for
Lymphoma, B-Cell
Medolution Ltd. 75
Early research (Phase 1)Study completedNCT00005021
What this trial is testing

Combination Chemotherapy With or Without Biological Therapy in Treating Patients With Refractory Solid Tumor or Lymphoma

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
Fox Chase Cancer Center 17
Testing effectiveness (Phase 2)WithdrawnNCT03212807
What this trial is testing

Study Of Durvalumab and Lenalidomide In R/R EBV Associated DLBCL Subtypes, Primary CNS And Testicular DLBCL

Who this might be right for
EBV Related Non-Hodgkin's LymphomaPrimary CNS LymphomaPrimary Testicular Lymphoma
Singapore General Hospital
Early research (Phase 1)Study completedNCT03703167
What this trial is testing

Ibrutinib With Rituximab and Lenalidomide for Patients With Recurrent/Refractory Primary or Secondary Central Nervous System Lymphoma (PCNSL/SCNSL)

Who this might be right for
Primary Central Nervous System Lymphoma (PCNSL)Secondary Central Nervous System Lymphoma (SCNSL)
Memorial Sloan Kettering Cancer Center 25
Load More Results